Publications in collaboration with researchers from Dana–Farber Cancer Institute (4)

2024

  1. Targeting the aminopeptidase ERAP enhances antitumor immunity by disrupting the NKG2A-HLA-E inhibitory checkpoint

    Immunity, Vol. 57, Núm. 12, pp. 2863-2878.e12

2023

  1. Leukemia-intrinsic determinants of CAR-T response revealed by iterative in vivo genome-wide CRISPR screening

    Nature Communications, Vol. 14, Núm. 1

2022

  1. In vivo CRISPR screens reveal the landscape of immune evasion pathways across cancer

    Nature Immunology, Vol. 23, Núm. 10, pp. 1495-1506

2019

  1. Loss of ADAR1 in tumours overcomes resistance to immune checkpoint blockade

    Nature, Vol. 565, Núm. 7737, pp. 43-48